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In Egypt, vaccination against pandemic (H1N1) 2009 
virus was required of pilgrims departing for the 2009 Hajj. A 
survey of 551 pilgrims as they returned to Egypt found 542 
(98.1% [weighted]) reported receiving the vaccine; 6 (1.0% 
[weighted]) were infected with inﬂ  uenza virus A (H3N2) but 
none with pandemic (H1N1) 2009 virus.
T
he annual Hajj pilgrimage brings >2.5 million pilgrims 
from >160 countries to Mecca and Medina in Saudi 
Arabia during a 1-week period (1). In the past, 6.0%–9.8% of 
Hajj pilgrims with acute respiratory tract infection have been 
found to have inﬂ  uenza (2–4). Seasonal inﬂ  uenza vaccine 
is recommended for pilgrims by Saudi Arabia’s Ministry of 
Health (5), but vaccination coverage has been low (4,6).
The Study
The Hajj occurs during the twelfth month of the 
Islamic calendar, a lunar calendar that shifts 11 days earlier 
each year. The 2009 Hajj took place during November 
25–28, (1430 AH), when the Northern Hemisphere was 
experiencing high pandemic (H1N1) 2009 virus activity, 
raising concern that the gathering could further contribute to 
the global spread of pandemic (H1N1) 2009. Health experts 
meeting in Jeddah in June 2009 made recommendations for 
reducing the pandemic’s effects during the Hajj (7). The 
value of predeparture vaccination was recognized, but 
it was thought unlikely that pandemic vaccine would be 
available in sufﬁ  cient quantities to have a major effect on 
transmission during the Hajj. Egypt received the vaccine in 
time to begin vaccinating pilgrims on November 3, 2009, 
and required predeparture vaccination for all pilgrims to 
protect them against illness and reduce the importation of 
pandemic (H1N1) 2009 into Egypt when they returned. 
Egypt also enforced the Jeddah group’s recommendation 
that the 2009 Hajj pilgrimage be made only by persons 
12–65 years of age.
Pandemic (H1N1) 2009 virus was ﬁ  rst detected in Egypt 
in June 2009. It did not become the predominant inﬂ  uenza 
virus causing inﬂ  uenza-like illness (ILI) in Egypt’s ILI 
sentinel surveillance system until mid-November 2009 (8).
Approximately 80,000 Egyptians make the Hajj 
pilgrimage each year, usually returning to Egypt a few days 
to a few weeks after it. In all, 70%–80% of pilgrims arrive 
at Cairo International Airport or Port Tawﬁ  q, near Suez 
(Ministry of Health, Egypt, unpub. data). During the peak 
return period, 7 or 8 ﬂ  ights arrive each day from Jeddah, 
with an average of 200–250 pilgrims per ﬂ  ight, and Port 
Tawﬁ  q receives 1 ship per day from Jeddah with ≈1,000–
1,200 pilgrims. The goal of the survey was to measure 
the prevalence of pandemic (H1N1) 2009 virus infection 
among returning pilgrims.
The survey was conducted by a team of 2 
epidemiologists, 2 health workers, and 2 laboratory 
technicians from the Preventive Sector, Egyptian Ministry 
of Health, during the peak return period. Every tenth 
pilgrim on the ship from Jeddah arriving at Port Tawﬁ  q 
on December 14, 2009, was selected for the survey sample 
without regard to illness status. At Cairo International 
Airport, pilgrims were selected from among all pilgrims 
on the 9 ﬂ   ights from Jeddah arriving during 9 AM–9 
PM on December 10–12, 2009. Because the survey was 
conducted at the baggage-claim area, probability sampling 
proved to be difﬁ  cult. With instructions to choose pilgrims 
throughout the area around the carousel without regard to 
age, sex, or illness status, the team selected a convenience 
sample of ≈50 pilgrims from each ﬂ  ight.
After providing verbal consent, pilgrims were asked 
their age, in which governorate they lived, and whether they 
had been vaccinated against pandemic (H1N1) 2009 virus. 
Their oropharynx was then swabbed, and swab specimens 
were placed in viral transport medium and kept in liquid 
nitrogen until transfer to the Ministry of Health’s Central 
Public Health Laboratory. All specimens were tested at the 
US Naval Medical Research Unit No. 3 in Cairo by real-
time reverse transcription PCR (rtRT-PCR) for inﬂ  uenza A 
viruses, and all specimens positive for inﬂ  uenza A viruses 
were tested for inﬂ  uenza A subtypes, including pandemic 
(H1N1) 2009 virus, by rtRT-PCR, according to guidelines 
of the World Health Organization and the Centers for 
Disease Control and Prevention (Atlanta, Georgia, USA) 
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(9). Testing was not performed for inﬂ  uenza B. A recent 
study found oropharyngeal swab samples to be sensitive 
than nasopharyngeal swab samples for detecting pandemic 
(H1N1) 2009 virus by rtRT-PCR (10).
Results were weighted according to probabilities 
of selection within the ship and each plane, which were 
considered separate strata. Data were analyzed with PROC 
SURVEYFREQ in SAS version 9.1 (SAS Institute Inc., 
Cary, NC, USA).
In all, 559 pilgrims were selected for the survey sample. 
Seven pilgrims refused to participate, and interview data 
were missing for 1 pilgrim, leaving 551 pilgrims in the 
analysis: 206 pilgrims from 4 ﬂ  ights on December 10, 219 
pilgrims from 5 ﬂ  ights on December 12, and 126 pilgrims 
from the ship arriving December 14. The stated age of 
549 (99.6%) of pilgrims in the sample was in the allowed 
age range of 12–65 years. Most were from the Cairo 
metropolitan area (43.8%) or Lower Egypt (51.0%); these 
areas were overrepresented compared with the proportion 
of the national population living in them (Table). All but 
9 (98.1%) pilgrims reported receiving a predeparture 
vaccination against pandemic (H1N1) 2009 virus. No 
association was found between predeparture vaccination 
status and sex (p = 0.38), age (<55 years vs. >55 years) (p 
= 0.95), or area of residence (Cairo metropolitan area vs. 
outside this area) (p = 0.20). In all, 6 (1.0%, 95% conﬁ  dence 
interval 0.2%–1.7%) pilgrims tested positive for inﬂ  uenza 
A. All had subtype H3N2. No pilgrim had positive results 
for pandemic (H1N1) 2009 virus.
This  ﬁ   nding supports the conclusion that returning 
pilgrims likely  contributed little to ongoing pandemic 
(H1N1) 2009 transmission in Egypt and is consistent 
with the intended effects of the predeparture vaccination 
requirement. At the time of the 2009 Hajj, pandemic 
(H1N1) 2009 was overwhelmingly the most common 
inﬂ  uenza virus in the Northern and Southern Hemispheres 
(12), and to our knowledge, few countries required 
predeparture vaccination against it. Thus, we expect that 
pilgrims were exposed to this virus during the Hajj, but the 
extent of exposure is uncertain. The only data of which we 
are aware that have been released thus far on the extent 
of such exposure were provided by the Minister of Health, 
Saudi Arabia, who announced on the last day of the Hajj 
that pandemic (H1N1) 2009 had been diagnosed in only 73 
persons during the Hajj (5 of whom died) (13). Haworth et 
al. have argued that a much larger number of cases is likely, 
on the basis of the expected case-fatality ratio among the 
Hajj pilgrims and on modeling results (14).
Our survey had several limitations. First, the results 
may not apply to pilgrims who returned to Egypt before or 
after the survey period. Second, pilgrims from Upper Egypt 
and coastal Egypt were underrepresented in the survey 
sample. Third, convenience sampling was used to select 
pilgrims arriving by plane. Fourth, unvaccinated pilgrims 
may have been reluctant to tell interviewers they had not 
been vaccinated because predeparture vaccination was 
required. Finally, some pilgrims may have been infected 
with pandemic (H1N1) 2009 virus shortly before swab 
samples were obtained but were not yet shedding virus.
Conclusions
Egypt demonstrated that it could implement a 
predeparture vaccination requirement despite late arrival 
of the vaccine, and our survey found no evidence that 
pilgrims returned to Egypt with pandemic (H1N1) 2009 
virus infection during the peak return period. These results 
may prompt other countries to consider a similar inﬂ  uenza 
vaccination policy before the Hajj and other mass gatherings 
where ampliﬁ   cation of inﬂ   uenza virus transmission is 
a major threat. Studies of vaccine effectiveness, cost-
effectiveness, and cost-beneﬁ   t in these settings would 
provide additional useful information.
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Table. Demographic characteristics, vaccination history, and 
influenza A infection prevalence among 551 pilgrims returning 
from the Hajj, Egypt, 2009 
Characteristic No. pilgrims (weighted %) 
Age group, y  
 <30  11  (2.2) 
 30–39  66  (12.4) 
 40–49  141  (23.9) 
 50–59  219  (40.2) 
 60–69  114  (21.2) 
 >70 0
 <12*  1  (0.3) 
 >65*  1  (0.1) 
Gender 
 M  311  (57.8) 
 F  240  (42.2) 
Area of residence† 
  Coastal Egypt  12 (3.1) 
  Lower Egypt  298 (51.0) 
  Cairo metropolitan area  232 (43.8) 
  Upper Egypt  9 (2.1) 
Verbal history of pandemic (H1N1) 2009 vaccination 
 Yes  542  (98.1) 
 No  9  (1.9) 
Pilgrims infected with influenza A virus, by subtype‡ 
 Seasonal  (H1N1)  0
  Seasonal (H3N2)  6 (1.0) 
  Pandemic (H1N1) 2009   0
*Outside the age limits recommended for Hajj pilgrims by the Ministry of 
Health, Saudi Arabia, and enforced by Egypt’s Ministry of Health. 
†The proportion of the national population living in these 4 areas according
to the 2006 census was 11.3%, 34.3%, 19.4%, and 34.9%, respectively 
(11). The areas were formed by grouping Egypt’s governorates as follows: 
Coastal Egypt: Alexandria, Damietta, Ismailia, Matrouh, North Sinai, Port-
Said, Suez, Red Sea; Lower Egypt: Behera, Dakahlia, Gharbia, Kafr-
ElSheikh, Menoufia, Sharkia; Cairo metropolitan area: Cairo, Giza, 
Kalyoubia; Upper Egypt: Aswan, Asyout, Beni-Suef, ElWadi ElGidid, 
Fayoum, Helwan, Luxor City, Menia, Qena, South Sinai, Suhag, and 6th 
October. 
‡By real-time reverse transcription PCR testing. Acknowledgments
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